Reviva Pharmaceuticals Holdings Inc (RVPH)
1.125
-0.08
(-7.02%)
USD |
NASDAQ |
Nov 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Max Drawdown (5Y): 94.95% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 94.95% |
| September 30, 2024 | 94.95% |
| August 31, 2024 | 94.95% |
| July 31, 2024 | 94.95% |
| June 30, 2024 | 94.95% |
| May 31, 2024 | 94.95% |
| April 30, 2024 | 94.95% |
| March 31, 2024 | 94.95% |
| February 29, 2024 | 94.95% |
| January 31, 2024 | 94.95% |
| December 31, 2023 | 94.95% |
| November 30, 2023 | 94.95% |
| October 31, 2023 | 94.95% |
| September 30, 2023 | 94.95% |
| August 31, 2023 | 94.95% |
| July 31, 2023 | 94.95% |
| June 30, 2023 | 94.95% |
| May 31, 2023 | 94.95% |
| April 30, 2023 | 94.95% |
| March 31, 2023 | 94.95% |
| February 28, 2023 | 94.95% |
| January 31, 2023 | 94.95% |
| December 31, 2022 | 94.95% |
| November 30, 2022 | 94.95% |
| October 31, 2022 | 94.95% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.95% |
| August 31, 2022 | 94.95% |
| July 31, 2022 | 94.65% |
| June 30, 2022 | 91.36% |
| May 31, 2022 | 88.47% |
| April 30, 2022 | 86.45% |
| March 31, 2022 | 86.45% |
| February 28, 2022 | 86.45% |
| January 31, 2022 | 86.45% |
| December 31, 2021 | 77.27% |
| November 30, 2021 | 72.31% |
| October 31, 2021 | 72.31% |
| September 30, 2021 | 72.31% |
| August 31, 2021 | 72.31% |
| July 31, 2021 | 70.54% |
| June 30, 2021 | 65.91% |
| May 31, 2021 | 65.91% |
| April 30, 2021 | 65.91% |
| March 31, 2021 | 54.55% |
| February 28, 2021 | 33.33% |
| January 31, 2021 | 33.33% |
| December 31, 2020 | 33.33% |
| November 30, 2020 | 10.14% |
| October 31, 2020 | 10.14% |
| September 30, 2020 | 10.14% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
7.14%
Minimum
Nov 2019
94.95%
Maximum
Aug 2022
68.12%
Average
87.46%
Median
Max Drawdown (5Y) Benchmarks
| Eyenovia Inc | 94.04% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -37.72 |
| Beta (5Y) | -0.0514 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 134.0% |
| Historical Sharpe Ratio (5Y) | -0.2865 |
| Historical Sortino (5Y) | -0.81 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.18% |